Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-driven refractory vascular malformations.

EMBO molecular medicine·2025
Same author

Fulminant Cardiac Sarcoidosis Successfully Treated With Aggressive Immunosuppressive Therapy.

Case reports in cardiology·2025
Same author

Involvement of lncRNA MIR205HG in idiopathic pulmonary fibrosis and IL-33 regulation via Alu elements.

JCI insight·2025
Same author

Thymic carcinoma recurring 11 years post-extended surgery: a case report.

General thoracic and cardiovascular surgery cases·2025
Same author

DECODE enables high-throughput mapping of antibody epitopes at single amino acid resolution.

PLoS biology·2025
Same author

Motor involvement in frontotemporal lobar degeneration with TAR DNA-binding protein of 43 kDa type C.

Neuropathology : official journal of the Japanese Society of Neuropathology·2025

Related Experiment Video

Updated: Jun 16, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Polymorphous lymphoproliferative disorder: a clinicopathological analysis.

Naoto Nakamichi1, Naoki Wada, Masaharu Kohara

  • 1Department of Pathology (C3), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Virchows Archiv : an International Journal of Pathology
|January 30, 2010
PubMed
Summary

Polymorphous lymphoproliferative disorder (LPD) is a rare, heterogeneous condition. This study found it often involves monoclonal B or T cell proliferation, can be EBV-associated, and typically presents as an aggressive lymphoma.

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Related Experiment Videos

Last Updated: Jun 16, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Polymorphous lymphoproliferative disorder (LPD) is characterized by a mixed cellular composition, often seen in immunodeficient individuals.
  • This study investigates clinicopathological features of polymorphous LPD in Japan.

Purpose of the Study:

  • To analyze the clinicopathological findings, clonality, Epstein-Barr virus (EBV) association, and prognosis of polymorphous LPD.

Main Methods:

  • Analysis of 19 cases of polymorphous LPD.
  • Southern blotting and/or polymerase chain reaction (PCR) for clonality assessment.
  • EBV detection.

Main Results:

  • Polymorphous LPD represented 0.4% of registered cases, with six cases having a history of rheumatoid arthritis and immunosuppressive agent use.
  • Monoclonal B-cell proliferation (B-LPD) and T-cell proliferation (T-LPD) were identified in 8 and 6 cases, respectively.
  • EBV was detected in some B-LPD, T-LPD, and polyclonal LPD cases. The 3-year overall survival rate was 49.7%.

Conclusions:

  • Polymorphous LPD is a rare, heterogeneous disease in Japan, often exhibiting monoclonal B or T cell proliferation.
  • The condition is occasionally EBV-associated and behaves aggressively, with a poor prognosis.
  • Further research is needed to understand its diverse origins and optimize treatment strategies.